NFkB is essential for activin-induced colorectal cancer migration via upregulation of PI3K-MDM2 pathway
Yazarlar (11)
Arundhati Jana
University of Illinois College of Medicine, Amerika Birleşik Devletleri
Nancy L Krett
University of Illinois College of Medicine, Amerika Birleşik Devletleri
Grace Guzman
University of Illinois College of Medicine, Amerika Birleşik Devletleri
Ahmer Khalid
University of Illinois College of Medicine, Amerika Birleşik Devletleri
Prof. Dr. Özkan ÖZDEN Kafkas Üniversitesi, Türkiye
Jonas J Staudacher
University of Illinois College of Medicine, Amerika Birleşik Devletleri
Jessica Bauer
University of Illinois College of Medicine, Amerika Birleşik Devletleri
Seung Hyun Baik
University of Illinois College of Medicine, Amerika Birleşik Devletleri
Timothy Carroll
University of Illinois College of Medicine, Amerika Birleşik Devletleri
Cemal Yazici
University of Illinois College of Medicine, Amerika Birleşik Devletleri
Barbara Jung
University of Illinois College of Medicine, Amerika Birleşik Devletleri
Devamını Göster...
Makale Türü Açık Erişim Özgün Makale (SCOPUS dergilerinde yayınlanan tam makale)
Dergi Adı Oncotarget
Dergi ISSN 1949-2553 Dergi Bilgileri (2017)
Dergi Tarandığı Indeksler SCI-Expanded
Makale Dili İngilizce Basım Tarihi 06-2017
Kabul Tarihi – Yayınlanma Tarihi 18-03-2017
Cilt / Sayı / Sayfa 8 / 23 / 37377–37393 DOI 10.18632/oncotarget.16343
Makale Linki http://www.oncotarget.com/abstract/16343
UAK Araştırma Alanları
Hayvan Fizyolojisi-Ekofizyolojisi
Özet
Colorectal cancer (CRC) remains a common and deadly cancer due to metastatic disease. Activin and TGFB (TGFβ) signaling are growth suppressive pathways that exert non-canonical pro-metastatic effects late in CRC carcinogenesis. We have recently shown that activin downregulates p21 via ubiquitination and degradation associated with enhanced cellular migration independent of SMADs. To investigate the mechanism of metastatic activin signaling, we examined activated NFkB signaling and activin ligand expression in CRC patient samples and found a strong correlation. We hypothesize that activation of the E3 ubiquitin ligase MDM2 by NFkB leads to p21 degradation in response to activin treatment. To dissect the link between activin and pro-carcinogenic NFkB signaling and downstream targets, we found that activin but not TGFB induced activation of NFkB leading to increased MDM2 ubiquitin ligase via PI3K. Further, overexpression of wild type p65 NFkB increased MDM2 expression while the NFkB inhibitors NEMObinding domain (NBD) and Bay11-7082 blocked the activin-induced increase in MDM2. In conclusion, in colon cancer cell migration, activin utilizes NFkB to induce MDM2 activity leading to the degradation of p21 in a PI3K dependent mechanism. This provides new mechanistic knowledge linking activin and NFkB signaling in advanced colon cancer which is applicable to targeted therapeutic interventions.
Anahtar Kelimeler
Activin | Colon cancer | MDM2 | Migration | NFkB
BM Sürdürülebilir Kalkınma Amaçları
Atıf Sayıları
Yöksis 20
Web of Science 68
Scopus 76
Google Scholar 111
PubMed 40
NFkB is essential for activin-induced colorectal cancer migration via upregulation of PI3K-MDM2 pathway